332 related articles for article (PubMed ID: 32414891)
1. Intravenous cangrelor and oral ticagrelor as an alternative to clopidogrel in acute intervention.
Linfante I; Ravipati K; Starosciak AK; Reyes D; Dabus G
J Neurointerv Surg; 2021 Jan; 13(1):30-32. PubMed ID: 32414891
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single-center pilot study.
Aguilar-Salinas P; Agnoletto GJ; Brasiliense LBC; Santos R; Granja MF; Gonsales D; Aghaebrahim A; Sauvageau E; Hanel RA
J Neurointerv Surg; 2019 Apr; 11(4):347-351. PubMed ID: 30552167
[TBL] [Abstract][Full Text] [Related]
3. Preliminary Experience with Cangrelor for Endovascular Treatment of Challenging Intracranial Aneurysms.
Abdennour L; Sourour N; Drir M; Premat K; Shotar E; Taylor G; Godier A; Mathout J; Lenck S; Bernard R; Carpentier A; Degos V; Clarençon F
Clin Neuroradiol; 2020 Sep; 30(3):453-461. PubMed ID: 31309241
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet Therapy During Emergent Extracranial Internal Carotid Artery Stenting: Comparison of Three Intravenous Antiplatelet Perioperative Strategies.
Delvoye F; Maier B; Escalard S; Labreuche J; Thion LA; Aknouche S; Hebert S; Redjem H; Smajda S; Ciccio G; Allard J; Sabben C; Obadia M; Maertens de Noordhout A; Olivot JM; Blanc R; Piotin M; Desilles JP; Mazighi M
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105521. PubMed ID: 33310073
[TBL] [Abstract][Full Text] [Related]
5. Use of Cangrelor in Cervical and Intracranial Stenting for the Treatment of Acute Ischemic Stroke: A "Real Life" Single-Center Experience.
Cervo A; Ferrari F; Barchetti G; Quilici L; Piano M; Boccardi E; Pero G
AJNR Am J Neuroradiol; 2020 Nov; 41(11):2094-2099. PubMed ID: 33033047
[TBL] [Abstract][Full Text] [Related]
6. Randomized Comparison of Oral P2Y
Hochholzer W; Kleiner P; Younas I; Valina CM; Löffelhardt N; Amann M; Bömicke T; Ferenc M; Hauschke D; Trenk D; Neumann FJ; Stratz C
JACC Cardiovasc Interv; 2017 Jan; 10(2):121-129. PubMed ID: 28104204
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials.
Vaduganathan M; Harrington RA; Stone GW; Deliargyris EN; Steg PG; Gibson CM; Hamm CW; Price MJ; Menozzi A; Prats J; Elkin S; Mahaffey KW; White HD; Bhatt DL
JAMA Cardiol; 2017 Feb; 2(2):127-135. PubMed ID: 27902833
[TBL] [Abstract][Full Text] [Related]
8. Utility of P2Y
Bohan CO; Wirtz MM; Hendrix P; Goren O; Schirmer CM; Islak C; Grassi DM; Dalal S; Weiner G; Griessenauer CJ
World Neurosurg; 2020 Oct; 142():e445-e452. PubMed ID: 32688033
[TBL] [Abstract][Full Text] [Related]
9. Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: a meta-analysis of randomized trials.
Tang XF; Fan JY; Meng J; Jin C; Yuan JQ; Yang YJ
Atherosclerosis; 2014 Apr; 233(2):568-578. PubMed ID: 24534451
[TBL] [Abstract][Full Text] [Related]
10. Safety and Tolerability of Transitioning from Cangrelor to Ticagrelor in Patients Who Underwent Percutaneous Coronary Intervention.
Badreldin HA; Carter D; Cook BM; Qamar A; Vaduganathan M; Bhatt DL
Am J Cardiol; 2017 Aug; 120(3):359-361. PubMed ID: 28576266
[TBL] [Abstract][Full Text] [Related]
11. Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Franchi F; Rollini F; Rivas A; Wali M; Briceno M; Agarwal M; Shaikh Z; Nawaz A; Silva G; Been L; Smairat R; Kaufman M; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
Circulation; 2019 Apr; 139(14):1661-1670. PubMed ID: 30630341
[TBL] [Abstract][Full Text] [Related]
12. Cangrelor dose titration using platelet function testing during cerebrovascular stent placement.
Entezami P; Holden DN; Boulos AS; Paul AR; Field NC; Nourollahzadeh E; Yamamoto J; Dalfino JC
Interv Neuroradiol; 2021 Feb; 27(1):88-98. PubMed ID: 32611215
[TBL] [Abstract][Full Text] [Related]
13. Periprocedural Neuroendovascular Antiplatelet Strategies for Thrombosis Prevention in Clopidogrel-Hyporesponsive Patients.
Barra ME; Berger K; Tesoro EP; Brophy GM
Pharmacotherapy; 2019 Mar; 39(3):317-334. PubMed ID: 30723937
[TBL] [Abstract][Full Text] [Related]
14. Cangrelor: a novel intravenous antiplatelet agent with a questionable future.
Waite LH; Phan YL; Spinler SA
Pharmacotherapy; 2014 Oct; 34(10):1061-76. PubMed ID: 25123696
[TBL] [Abstract][Full Text] [Related]
15. Cangrelor and Stenting in Acute Ischemic Stroke : Monocentric Case Series.
Elhorany M; Lenck S; Degos V; Sourour NA; Frasca Polara G; Shotar E; Godier A; Drir M; Mahtout J; Premat K; Alamowitch S; Samson Y; Clarençon F
Clin Neuroradiol; 2021 Jun; 31(2):439-448. PubMed ID: 32382875
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic effects during the transition between cangrelor and ticagrelor.
Schneider DJ; Agarwal Z; Seecheran N; Keating FK; Gogo P
JACC Cardiovasc Interv; 2014 Apr; 7(4):435-42. PubMed ID: 24656538
[TBL] [Abstract][Full Text] [Related]
17. Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial.
Stone GW; Généreux P; Harrington RA; White HD; Gibson CM; Steg PG; Hamm CW; Mahaffey KW; Price MJ; Prats J; Deliargyris EN; Bhatt DL
Eur Heart J; 2018 Dec; 39(46):4112-4121. PubMed ID: 30203006
[TBL] [Abstract][Full Text] [Related]
18. The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.
Gutierrez JA; Harrington RA; Blankenship JC; Stone GW; Steg PG; Gibson CM; Hamm CW; Price MJ; Généreux P; Prats J; Deliargyris EN; Mahaffey KW; White HD; Bhatt DL;
Eur Heart J; 2016 Apr; 37(14):1122-30. PubMed ID: 26400827
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series.
Bowman S; Gass J; Weeks P
Ann Pharmacother; 2019 Feb; 53(2):171-177. PubMed ID: 30132336
[TBL] [Abstract][Full Text] [Related]
20. The use of cangrelor in neurovascular interventions: a multicenter experience.
Cortez GM; Monteiro A; Sourour N; Clarençon F; Elhorany M; Grigoryan M; Mirza S; Dabus G; Linfante I; Aguilar-Salinas P; Murtaza Y; Aghaebrahim A; Sauvageau E; Hanel RA
Neuroradiology; 2021 Jun; 63(6):925-934. PubMed ID: 33174182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
